The importance of TLR signaling has been investigated in CLL, revealing that stimulation of this receptor family can protect from apoptosis and correlates (through activation of NF-κB and STAT3) with poor prognosis [126,127]. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.